423 related articles for article (PubMed ID: 16802521)
1. [Chronic inflammatory bowel disease and cardiovascular complications].
Rellecke P; Strauer BE
Med Klin (Munich); 2006 Mar; 101 Suppl 1():56-60. PubMed ID: 16802521
[TBL] [Abstract][Full Text] [Related]
2. Antineutrophil cytoplasmic antibodies in Estonian patients with inflammatory bowel disease. Prevalence and diagnostic role.
Kull K; Salupere R; Uibo R; Ots M; Salupere V
Hepatogastroenterology; 1998; 45(24):2132-7. PubMed ID: 9951879
[TBL] [Abstract][Full Text] [Related]
3. Antineutrophil cytoplasmic antibodies in inflammatory bowel disease: diagnostic tool or research procedure?
Andreani ML; Frascà G; Brusco G; Borgnino L; Biagi F; Gasbarrini G; Corazza GR
Ann Ital Med Int; 1996; 11(4):254-7. PubMed ID: 9050283
[TBL] [Abstract][Full Text] [Related]
4. [Extraintestinal manifestations of inflammatory bowel disease].
Rogler G; Schölmerich J
Med Klin (Munich); 2004 Mar; 99(3):123-30. PubMed ID: 15024484
[TBL] [Abstract][Full Text] [Related]
5. Antineutrophil cytoplasmic autoantibodies and anti-Saccharomyces cerevisiae antibodies in inflammatory bowel diseases.
Kiliç ZM; Tunç B; Ayaz S; Filik L; Aktaş S; Parlak E; Ulker A
Turk J Gastroenterol; 2004 Dec; 15(4):238-42. PubMed ID: 16249978
[TBL] [Abstract][Full Text] [Related]
6. Anti-neutrophil cytoplasmic antibodies in Brazilian patients with inflammatory bowel disease.
Cabral VL; Miszputen SJ; Catapani WR
Hepatogastroenterology; 2003; 50(50):412-5. PubMed ID: 12749235
[TBL] [Abstract][Full Text] [Related]
7. Paediatric inflammatory bowel disease in New Zealand.
Yap J; Wesley A; Mouat S; Chin S
N Z Med J; 2008 Oct; 121(1283):19-34. PubMed ID: 18841182
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic yield of capsule endoscopy in ulcerative colitis and inflammatory bowel disease of unclassified type (IBDU).
Mehdizadeh S; Chen G; Enayati PJ; Cheng DW; Han NJ; Shaye OA; Ippoliti A; Vasiliauskas EA; Lo SK; Papadakis KA
Endoscopy; 2008 Jan; 40(1):30-5. PubMed ID: 18058654
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary complications in patients with inflammatory bowel disease.
Kuzela L; Vavrecka A; Prikazska M; Drugda B; Hronec J; Senkova A; Drugdova M; Oltman M; Novotna T; Brezina M; Kratky A; Kristufek P
Hepatogastroenterology; 1999; 46(27):1714-9. PubMed ID: 10430329
[TBL] [Abstract][Full Text] [Related]
10. [Inflammatory intestinal diseases and their extra-intestinal manifestations observed at Liban].
Ghayad E; Haddad F; el Aam C; Tohmé A; Nasr W
J Med Liban; 1997 Dec; 45(4):191-6. PubMed ID: 9747008
[TBL] [Abstract][Full Text] [Related]
11. Association of primary sclerosing cholangitis with inflammatory bowel diseases: a prospective study.
Purrmann J; Mödder U; Cleveland S; Seibold F; Burchard A; Gemsa R; Lübke H
Z Gastroenterol; 1993 Nov; 31 Suppl 5():56-9. PubMed ID: 8197804
[No Abstract] [Full Text] [Related]
12. [Cutaneous and mucosal manifestations of inflammatory bowel diseases].
Károlyi Z; Erós N; Ujszászy L; Nagy G
Orv Hetil; 2000 Jun; 141(25):1391-5. PubMed ID: 10934882
[TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics of inflammatory bowel disease in Thailand: a 16 years review.
Rerknimitr R; Chalapipat O; Kongkam P; Mb PK
J Med Assoc Thai; 2005 Sep; 88 Suppl 4():S129-33. PubMed ID: 16623017
[TBL] [Abstract][Full Text] [Related]
14. [Association of Takayasu's arteritis and inflammatory bowel disease (author's transl)].
Beau B; Colasse W; Le Bihan G; Bourreille J
Sem Hop; 1980 Nov 18-25; 56(43-44):1841-5. PubMed ID: 6109376
[TBL] [Abstract][Full Text] [Related]
15. Extraintestinal manifestations of idiopathic inflammatory bowel disease.
Danzi JT
Arch Intern Med; 1988 Feb; 148(2):297-302. PubMed ID: 3277559
[TBL] [Abstract][Full Text] [Related]
16. The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study.
Bernstein CN; Blanchard JF; Rawsthorne P; Yu N
Am J Gastroenterol; 2001 Apr; 96(4):1116-22. PubMed ID: 11316157
[TBL] [Abstract][Full Text] [Related]
17. Antibodies to Escherichia coli outer membrane porin C in the absence of anti-Saccharomyces cerevisiae antibodies and anti-neutrophil cytoplasmic antibodies are an unreliable marker of Crohn disease and ulcerative colitis.
Davis MK; Andres JM; Jolley CD; Novak DA; Haafiz AB; González-Peralta RP
J Pediatr Gastroenterol Nutr; 2007 Oct; 45(4):409-13. PubMed ID: 18030205
[TBL] [Abstract][Full Text] [Related]
18. HLA antigens and anti-neutrophil cytoplasmic antibodies (ANCA) in inflammatory bowel disease.
García Herola A; Nos P; Hinijosa J; Hoyos M; Molés JR; Carmona E; Puig N; Sánchez-Cuenca JM; Ponce J; Berenguer J
Rev Esp Enferm Dig; 2003 Nov; 95(11):760-4, 755-9. PubMed ID: 14640873
[TBL] [Abstract][Full Text] [Related]
19. CARD15 mutations in Dutch familial and sporadic inflammatory bowel disease and an overview of European studies.
van der Linde K; Boor PP; Houwing-Duistermaat JJ; Crusius BJ; Wilson PJ; Kuipers EJ; de Rooij FW
Eur J Gastroenterol Hepatol; 2007 Jun; 19(6):449-59. PubMed ID: 17489054
[TBL] [Abstract][Full Text] [Related]
20. [The eye and chronic inflammatory diseases of the intestines. Immunopathological and genetic aspects. Apropos of 3 cases].
Raby O; Salvanet-Bouccara A; Forestier F
J Fr Ophtalmol; 1987; 10(11):683-98. PubMed ID: 3329203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
